Cholesterol oxidase is a flavoenzyme that catalyzes the oxidation and isomerization of cholesterol to cholest-4-en-3-one. Cholesterol oxidase is used commercially for the determination of serum cholesterol concentrations, is insecticidal, and is used to study membrane structure. Recent evidence suggests that cholesterol oxidase may be involved in the pathogenesis of some microorganisms such as Rhodococcus equi and Mycobacterium tuberculosis. The studies proposed will provide a precise molecular model of the lipid requirements for activity and of the pathway to flavin oxidation. These models are important for the development of cholesterol oxidase as a commercial product, as a useful and reliable tool in the study of cellular membranes for monitoring lipid rafts, for investigating the role of cholesterol oxidase in bacterial pathogenesis, and for developing anti-bacterial inhibitors. The specific hypotheses that will be tested are that 1) cholesterol oxidase can distinguish between cholesterol-containing lipid domains of different composition in the same membrane, i.e., between liquid-disordered domains and liquid-ordered domains (rafts);2) the enzyme employs a large interface to associate with the lipid bilayer during catalysis;and 3) a gated tunnel between the solvent and the flavin at the active site controls oxygen access.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053306-14
Application #
7582421
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Ershow, Abby
Project Start
1994-12-01
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2010-11-30
Support Year
14
Fiscal Year
2009
Total Cost
$293,892
Indirect Cost
Name
State University New York Stony Brook
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Schaefer, Christin M; Lu, Rui; Nesbitt, Natasha M et al. (2015) FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis. Structure 23:21-33
Yang, Meng; Guja, Kip E; Thomas, Suzanne T et al. (2014) A distinct MaoC-like enoyl-CoA hydratase architecture mediates cholesterol catabolism in Mycobacterium tuberculosis. ACS Chem Biol 9:2632-45
Gao, Jin; Sampson, Nicole S (2014) A GMC oxidoreductase homologue is required for acetylation of glycopeptidolipid in Mycobacterium smegmatis. Biochemistry 53:611-3
Wipperman, Matthew F; Sampson, Nicole S; Thomas, Suzanne T (2014) Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49:269-93
Su, Chiao-Yung; London, Erwin; Sampson, Nicole S (2013) Mapping peptide thiol accessibility in membranes using a quaternary ammonium isotope-coded mass tag (ICMT). Bioconjug Chem 24:1235-47
Slayden, Richard A; Jackson, Mary; Zucker, Jeremy et al. (2013) Updating and curating metabolic pathways of TB. Tuberculosis (Edinb) 93:47-59
Thomas, Suzanne T; Sampson, Nicole S (2013) Mycobacterium tuberculosis utilizes a unique heterotetrameric structure for dehydrogenation of the cholesterol side chain. Biochemistry 52:2895-904
Wipperman, Matthew F; Yang, Meng; Thomas, Suzanne T et al. (2013) Shrinking the FadE proteome of Mycobacterium tuberculosis: insights into cholesterol metabolism through identification of an ?2?2 heterotetrameric acyl coenzyme A dehydrogenase family. J Bacteriol 195:4331-41
Thomas, Suzanne T; VanderVen, Brian C; Sherman, David R et al. (2011) Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism. J Biol Chem 286:43668-78
Thomas, Suzanne T; Yang, Xinxin; Sampson, Nicole S (2011) Inhibition of the M. tuberculosis 3?-hydroxysteroid dehydrogenase by azasteroids. Bioorg Med Chem Lett 21:2216-9

Showing the most recent 10 out of 19 publications